These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19754465)

  • 1. Structure-function studies for the panacea, valproic acid.
    Terbach N; Williams RS
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1126-32. PubMed ID: 19754465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
    Isoherranen N; Yagen B; Bialer M
    Curr Opin Neurol; 2003 Apr; 16(2):203-11. PubMed ID: 12644750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
    Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
    Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood stabilizers: protecting the mood...protecting the brain.
    Brunello N
    J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).
    Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H
    Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid.
    Shimshoni JA; Bialer M; Wlodarczyk B; Finnell RH; Yagen B
    J Med Chem; 2007 Dec; 50(25):6419-27. PubMed ID: 17994680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile.
    Mishra MK; Kukal S; Paul PR; Bora S; Singh A; Kukreti S; Saso L; Muthusamy K; Hasija Y; Kukreti R
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure.
    Eickholt BJ; Towers GJ; Ryves WJ; Eikel D; Adley K; Ylinen LM; Chadborn NH; Harwood AJ; Nau H; Williams RS
    Mol Pharmacol; 2005 May; 67(5):1426-33. PubMed ID: 15687223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.
    Kaufmann D; Bialer M; Shimshoni JA; Devor M; Yagen B
    J Med Chem; 2009 Nov; 52(22):7236-48. PubMed ID: 19877649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect.
    Bojic U; Elmazar MM; Hauck RS; Nau H
    Chem Res Toxicol; 1996; 9(5):866-70. PubMed ID: 8828922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DP-VPA D-Pharm.
    Labiner DM
    Curr Opin Investig Drugs; 2002 Jun; 3(6):921-3. PubMed ID: 12137414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
    Rosenberg G
    Cell Mol Life Sci; 2007 Aug; 64(16):2090-103. PubMed ID: 17514356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myo-inositol enhances teratogenicity of valproic acid in the mouse.
    Massa V; Wlodarczyk B; Giavini E; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2006 Mar; 76(3):200-4. PubMed ID: 16511884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
    Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
    Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New generation of valproic acid.
    Trojnar MK; Wierzchowska-Cioch E; Krzyzanowski M; Jargiełło M; Czuczwar SJ
    Pol J Pharmacol; 2004; 56(3):283-8. PubMed ID: 15215557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
    Okada A; Onishi Y; Yagen B; Shimshoni JA; Kaufmann D; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in
    Kelly E; Sharma D; Wilkinson CJ; Williams RSB
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice.
    Schank JR; Liles LC; Weinshenker D
    Epilepsy Res; 2005 Jun; 65(1-2):23-31. PubMed ID: 15955669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.